Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 20 December

Bell Direct
December 20, 2024

Morning Bell 19 December

Bell Direct
December 19, 2024

Morning Bell 18 December

Bell Direct
December 18, 2024

Morning Bell 17 December

Bell Direct
December 17, 2024

Morning Bell 16 December

Bell Direct
December 16, 2024

Weekly Wrap 13 December

Bell Direct
December 13, 2024

Morning Bell 12 December

Bell Direct
December 12, 2024

Morning Bell 11 December

Bell Direct
December 11, 2024

Morning Bell 10 December

Bell Direct
December 10, 2024

Morning Bell 9 December

Bell Direct
December 9, 2024

Weekly Wrap 6 December

Bell Direct
December 6, 2024